Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002207 · ClinicalTrials.gov registry record · NA
A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients
A NA study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- NA
- Development phase
NCT00002207 is a NA study that has completed, run by Bristol-Myers Squibb.
The verdict
NCT00002207, a NA study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The purpose of this study is to compare the effectiveness of taking didanosine (ddI) once a day plus stavudine (d4T) twice a day with taking ddI twice a day plus d4T twice a day. This study also examines the safety of giving ddI with d4T in the short-term.
Interventions
- DRUG Stavudine
- DRUG Didanosine
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-02 |
| Est. Completion | 2004-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002207
The ClinicalTrials.gov registry entry for NCT00002207 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stavudine is the first listed.
NCT00002207 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002207 about?
NCT00002207 is a clinical study titled "A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients". The purpose of this study is to compare the effectiveness of taking didanosine (ddI) once a day plus stavudine (d4T) twice a day with taking ddI twice a day plus d4T twice a day. This study also examines the safety of giving ddI with d4T in the short-term.
What is the current status of trial NCT00002207?
This trial is currently completed. It is a NA study. The study started on 2004-02. Estimated completion is 2004-02.
What interventions are being tested in trial NCT00002207?
The interventions under investigation include: Stavudine (DRUG), Didanosine (DRUG).
Who is sponsoring clinical trial NCT00002207?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.